Showing 1 - 11 results of 11 for search 'Shiqiao Ye', query time: 0.05s Refine Results
  1. 1
    Creation of iPSC line NCHi004-A from a patient with down syndrome and congenital heart defects

    Creation of iPSC line NCHi004-A from a patient with down syndrome and congenital heart defects by Matthew Alonzo, Shiqiao Ye, Brian Beckman, Karen Texter, Vidu Garg, Ming-Tao Zhao

    Published 2023-09-01
    Get full text
    Article
  2. 2
    Establishment of NCHi009-A, an iPSC line from a patient with hypoplastic left heart syndrome (HLHS) carrying a heterozygous NOTCH1 mutation

    Establishment of NCHi009-A, an iPSC line from a patient with hypoplastic left heart syndrome (HLHS) carrying a heterozygous NOTCH1 mutation by Subhodip Adhicary, Shiqiao Ye, Hui Lin, Karen Texter, Vidu Garg, Ming-Tao Zhao

    Published 2023-02-01
    Get full text
    Article
  3. 3
    Generation and characterization of a human induced pluripotent stem cell line heterozygous for a NOTCH1 mutation (NCHi014-A)

    Generation and characterization of a human induced pluripotent stem cell line heterozygous for a NOTCH1 mutation (NCHi014-A) by Mona Aljuhani, Talita Z. Choudhury, Yang Yu, Shiqiao Ye, Mingtao Zhao, Vidu Garg

    Published 2024-02-01
    Get full text
    Article
  4. 4
    Generation of an induced pluripotent stem cell line (NCHi010-A) from a 6-year-old female with Down syndrome and without congenital heart disease

    Generation of an induced pluripotent stem cell line (NCHi010-A) from a 6-year-old female with Down syndrome and without congenital heart disease by Yang Yu, Matthew Alonzo, Shiqiao Ye, Anne Fang, Kandamurugu Manickam, Vidu Garg, Ming-Tao Zhao

    Published 2023-09-01
    Get full text
    Article
  5. 5
    Characterization of an induced pluripotent stem cell line NCHi011-A from a 23-year-old female with Alagille Syndrome harboring a heterozygous JAG1 pathogenic variant

    Characterization of an induced pluripotent stem cell line NCHi011-A from a 23-year-old female with Alagille Syndrome harboring a heterozygous JAG1 pathogenic variant by Isaac Stanberry, David Cunningham, Shiqiao Ye, Matthew Alonzo, Ming-Tao Zhao, Vidu Garg, Brenda Lilly

    Published 2023-10-01
    Get full text
    Article
  6. 6
    Generation of iPSC line NCHi012-A from a patient with Alagille syndrome and heterozygous pathogenic variant in the JAG1 gene

    Generation of iPSC line NCHi012-A from a patient with Alagille syndrome and heterozygous pathogenic variant in the JAG1 gene by David Cunningham, Isaac Stanberry, Shiqiao Ye, Matthew Alonzo, Ming-Tao Zhao, Vidu Garg, Brenda Lilly

    Published 2023-09-01
    Get full text
    Article
  7. 7
    Cardiomyocyte Proliferation and Maturation: Two Sides of the Same Coin for Heart Regeneration

    Cardiomyocyte Proliferation and Maturation: Two Sides of the Same Coin for Heart Regeneration by Ming-Tao Zhao, Ming-Tao Zhao, Ming-Tao Zhao, Shiqiao Ye, Juan Su, Vidu Garg, Vidu Garg, Vidu Garg, Vidu Garg

    Published 2020-10-01
    Get full text
    Article
  8. 8
    Characterization of an iPSC line NCHi006-A from a patient with hypoplastic left heart syndrome (HLHS)

    Characterization of an iPSC line NCHi006-A from a patient with hypoplastic left heart syndrome (HLHS) by Matthew Alonzo, Javier Contreras, Shiqiao Ye, Hui Lin, Lumariz Hernandez-Rosario, Kim L. McBride, Karen Texter, Vidu Garg, Ming-Tao Zhao

    Published 2022-10-01
    Get full text
    Article
  9. 9
    Generation of an induced pluripotent stem cell line NCHi003-A from a 11-year-old male with pulmonary atresia with intact ventricular septum (PA-IVS)

    Generation of an induced pluripotent stem cell line NCHi003-A from a 11-year-old male with pulmonary atresia with intact ventricular septum (PA-IVS) by Javier Contreras, Matthew Alonzo, Shiqiao Ye, Hui Lin, Lumariz Hernandez-Rosario, Kim L. McBride, Karen Texter, Vidu Garg, Ming-Tao Zhao

    Published 2022-10-01
    Get full text
    Article
  10. 10
    LIS1 regulates osteoclast formation and function through its interactions with dynein/dynactin and Plekhm1.

    LIS1 regulates osteoclast formation and function through its interactions with dynein/dynactin and Plekhm1. by Shiqiao Ye, Tristan W Fowler, Nathan J Pavlos, Pei Ying Ng, Kai Liang, Yunfeng Feng, Minghao Zheng, Richard Kurten, Stavros C Manolagas, Haibo Zhao

    Published 2011-01-01
    Get full text
    Article
  11. 11
    Characterization of the molecular mechanism of the bone-anabolic activity of carfilzomib in multiple myeloma.

    Characterization of the molecular mechanism of the bone-anabolic activity of carfilzomib in multiple myeloma. by Bo Hu, Yu Chen, Saad Z Usmani, Shiqiao Ye, Wei Qiang, Xenofon Papanikolaou, Christoph J Heuck, Shmuel Yaccoby, Bart O Williams, Frits Van Rhee, Bart Barlogie, Joshua Epstein, Ya-Wei Qiang

    Published 2013-01-01
    Get full text
    Article

Search Tools: